FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2606231884> ?p ?o ?g. }

• W2606231884 endingPage "91" @default.
• W2606231884 startingPage "84" @default.
• W2606231884 abstract "Background: Our study evaluated progression of and identified potential factors contributing to outcomes of ROME III defined-functional gastrointestinal disorders (FGIDs) in children treated symptomatically in a biopsychosocial model of care with a long-term follow-up. Methods: We performed a retrospective review of pediatric patients who were diagnosed with ROME III defined-FGIDs including functional abdominal pain, functional dyspepsia, irritable bowel syndrome and abdominal migraine. Patients were managed symptomatically in a biopsychosocial model of care from the time of initial diagnosis. Demographics, management, progression and response to treatment assessed as complete, partial, and no improvement were reviewed. Results: Two hundred fifty-eight patients were included with mean age of 10.6 years, female 55.4%, mean number of encounters 3.3 visits, and mean follow-up was 18.7 months (range 2 - 59, SD 15.8). Diagnoses were functional abdominal pain 45%, irritable bowel syndrome 20.9%, multiple 13.2%, functional dyspepsia 12.8%, and abdominal migraine 8.1%. Investigations were performed in most patients: laboratory studies in 93.4% (non-contributory abnormal 23.6%), imaging studies in 45.3% (non-contributory abnormal 5%) and endoscopies in 43.0% (non-contributory abnormal 1.2%). Treatment included medication in 93.7%, and surgery in 1.9% (normal pathology). There were new functional gastrointestinal diagnosis in 11.6%, evolution of FGIDs, from one to another in 12.0%, and recurrence found in 35.7% of patients. There were 60.1% patients in the complete improvement group (CIG) and 39.1% in the partial/no improvement group (PIG/NIG). No statistical difference was found between CIG and PIG/NIG regarding demographics or evaluation. PIG/NIG had more encounters (mean 3.63 vs. 3.11; P = 0.03), had non-contributory lab abnormalities (34.4% vs. 20.0%; P = 0.01), needed more endoscopies (52.4% vs. 36.8%; P = 0.02), required more treatment changes (mean 1.41 vs. 0.81; P < 0.01) and developed new functional gastrointestinal diagnoses (19.4% vs. 6.5%; P < 0.01) with long-term follow-up. Conclusions: Patients with ROME III defined-FGIDs who experience partial or no improvement with treatment develop new FGID diagnosis, need more number of follow-up visits, require more number of endoscopies, need more treatment changes, and have more non-contributory laboratory abnormalities, compared to those who experience complete improvement. Symptomatic treatment offered in a biopsychosocial model of care is possibly beneficial in managing children with FGIDs. Gastroenterol Res. 2017;10(2):84-91 doi: https://doi.org/10.14740/gr798w" @default.
• W2606231884 created "2017-04-28" @default.
• W2606231884 creator A5044536676 @default.
• W2606231884 creator A5048133440 @default.
• W2606231884 creator A5050289218 @default.
• W2606231884 creator A5088871212 @default.
• W2606231884 date "2017-01-01" @default.
• W2606231884 modified "2023-09-25" @default.
• W2606231884 title "Long-Term Study of Children With ROME III Functional Gastrointestinal Disorders Managed Symptomatically in a Biopsychosocial Model" @default.
• W2606231884 cites W114285741 @default.
• W2606231884 cites W1550531151 @default.
• W2606231884 cites W1591865274 @default.
• W2606231884 cites W1710077504 @default.
• W2606231884 cites W1864069650 @default.
• W2606231884 cites W1965740377 @default.
• W2606231884 cites W1977273549 @default.
• W2606231884 cites W1989974160 @default.
• W2606231884 cites W1994080685 @default.
• W2606231884 cites W1998351388 @default.
• W2606231884 cites W2003432072 @default.
• W2606231884 cites W2010998425 @default.
• W2606231884 cites W2025209583 @default.
• W2606231884 cites W2027731587 @default.
• W2606231884 cites W2039884246 @default.
• W2606231884 cites W2041860905 @default.
• W2606231884 cites W2062736068 @default.
• W2606231884 cites W2064861950 @default.
• W2606231884 cites W2064893789 @default.
• W2606231884 cites W2065173261 @default.
• W2606231884 cites W2070888548 @default.
• W2606231884 cites W2071001644 @default.
• W2606231884 cites W2077647940 @default.
• W2606231884 cites W2081353332 @default.
• W2606231884 cites W2091594934 @default.
• W2606231884 cites W2105033346 @default.
• W2606231884 cites W2124043821 @default.
• W2606231884 cites W2135236679 @default.
• W2606231884 cites W2145184220 @default.
• W2606231884 cites W2156059840 @default.
• W2606231884 cites W2156286274 @default.
• W2606231884 cites W2284157568 @default.
• W2606231884 cites W2315143998 @default.
• W2606231884 cites W2329696302 @default.
• W2606231884 cites W2398112952 @default.
• W2606231884 doi "https://doi.org/10.14740/gr798w" @default.
• W2606231884 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5412540" @default.
• W2606231884 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28496528" @default.
• W2606231884 hasPublicationYear "2017" @default.
• W2606231884 type Work @default.
• W2606231884 sameAs 2606231884 @default.
• W2606231884 citedByCount "6" @default.
• W2606231884 countsByYear W26062318842018 @default.
• W2606231884 countsByYear W26062318842020 @default.
• W2606231884 countsByYear W26062318842021 @default.
• W2606231884 countsByYear W26062318842022 @default.
• W2606231884 crossrefType "journal-article" @default.
• W2606231884 hasAuthorship W2606231884A5044536676 @default.
• W2606231884 hasAuthorship W2606231884A5048133440 @default.
• W2606231884 hasAuthorship W2606231884A5050289218 @default.
• W2606231884 hasAuthorship W2606231884A5088871212 @default.
• W2606231884 hasBestOaLocation W26062318841 @default.
• W2606231884 hasConcept C118552586 @default.
• W2606231884 hasConcept C126322002 @default.
• W2606231884 hasConcept C137886200 @default.
• W2606231884 hasConcept C142724271 @default.
• W2606231884 hasConcept C144024400 @default.
• W2606231884 hasConcept C149923435 @default.
• W2606231884 hasConcept C2778188384 @default.
• W2606231884 hasConcept C2778271842 @default.
• W2606231884 hasConcept C2780084366 @default.
• W2606231884 hasConcept C2780120127 @default.
• W2606231884 hasConcept C2780955771 @default.
• W2606231884 hasConcept C534262118 @default.
• W2606231884 hasConcept C71924100 @default.
• W2606231884 hasConceptScore W2606231884C118552586 @default.
• W2606231884 hasConceptScore W2606231884C126322002 @default.
• W2606231884 hasConceptScore W2606231884C137886200 @default.
• W2606231884 hasConceptScore W2606231884C142724271 @default.
• W2606231884 hasConceptScore W2606231884C144024400 @default.
• W2606231884 hasConceptScore W2606231884C149923435 @default.
• W2606231884 hasConceptScore W2606231884C2778188384 @default.
• W2606231884 hasConceptScore W2606231884C2778271842 @default.
• W2606231884 hasConceptScore W2606231884C2780084366 @default.
• W2606231884 hasConceptScore W2606231884C2780120127 @default.
• W2606231884 hasConceptScore W2606231884C2780955771 @default.
• W2606231884 hasConceptScore W2606231884C534262118 @default.
• W2606231884 hasConceptScore W2606231884C71924100 @default.
• W2606231884 hasIssue "2" @default.
• W2606231884 hasLocation W26062318841 @default.
• W2606231884 hasLocation W26062318842 @default.
• W2606231884 hasLocation W26062318843 @default.
• W2606231884 hasLocation W26062318844 @default.
• W2606231884 hasOpenAccess W2606231884 @default.
• W2606231884 hasPrimaryLocation W26062318841 @default.
• W2606231884 hasRelatedWork W1966902248 @default.
• W2606231884 hasRelatedWork W2003432072 @default.
• W2606231884 hasRelatedWork W2078565093 @default.
• W2606231884 hasRelatedWork W2143469354 @default.

• next